Variable | Univariate meta-regression analysis | ||||
ECG modality | n | R2 | Coefficient (95% CI) | P value | |
Days of monitoring | ILR | 23 | 54.0% | 0.0013 (0.0006 to 0.0020) | <0.0001 |
MCOT | 19 | 29.3% | 0.0297 (–0.0045 to 0.0638) | 0.085 | |
Inpatient | 7 | 0.0% | 0.0874 (–0.2226 to 0.3974) | 0.50 | |
Age (years) | ILR | 23 | 39.7% | 0.0675 (0.0253 to 0.1098) | 0.0032 |
MCOT | 19 | 46.3% | 0.0378 (0.0065 to 0.0692) | 0.021 | |
Inpatient | 7 | 64.9% | 0.1037 (0.0156 to 0.1919) | 0.029 | |
CHA₂DS₂-VASc | ILR | 21 | 3.9% | 0.1930 (–0.1311 to 0.5172) | 0.23 |
MCOT | 11 | 2.2% | 0.2669 (–0.4402 to 0.9740) | 0.42 | |
Inpatient | 4 | 0.0% | −0.2806 (–2.3491 to 1.7878) | 0.62 | |
NIHSS | ILR | 9 | 25.5% | 1.8005 (–0.0525 to 0.3878) | 0.11 |
MCOT | 9 | 23.4% | −0.0891 (–0.2424 to 0.0643) | 0.21 | |
Inpatient | 4 | 87.4% | 0.1212 (–0.0714 to 0.3137) | 0.11 | |
Modified Rankin scale | MCOT | 3 | 0.0% | −0.1646 (–11.4354 to 11.1061) | 0.88 |
LVEF | ILR | 5 | 45.2% | 0.2669 (–0.1940 to 0.7278) | 0.16 |
MCOT | 6 | 0.0% | 0.0003 (–0.0345 to 0.0351) | 0.98 |
Values in bold are statistically significant (<0.05).
ILR, implantable loop recorder; LVEF, left ventricular ejection fraction; MCOT, mobile cardiac outpatient telemetry; NIHSS, National Institutes of Health Stroke Scale.